3E07016
Introduction Coronary Artery to Recombinant Human-activated Protein C with Thrombolytic, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 3 Administration |
| Body System | E Physiological Systems and Anatomical Regions |
| Operation | 0 Introduction |
| Body Part | 7 Coronary Artery |
| Approach | 0 Open |
| Device | 1 Thrombolytic |
| Qualifier | 6 Recombinant Human-activated Protein C |
Operation Definition
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
Procedure Overview
Introduction covers putting a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance into or onto a body region, other than blood or blood products, which fall under Transfusion instead. This wide-ranging family includes things like injecting anesthesia, infusing chemotherapy, instilling contrast for imaging, delivering anti-infective medications, or providing nutritional formula through a feeding route.
Because it spans so many substance types and delivery sites, this is one of the most frequently used families in the Administration section. A patient might encounter it during an epidural injection, a course of intravenous antibiotics, contrast dye given before a CT scan, or tube feeding after surgery; each represents a substance being placed into the body to achieve a specific therapeutic or diagnostic goal rather than a physical alteration of tissue.
Anatomy & Axis Detail
Coronary Artery
Introduction into a coronary artery most often means catheter-directed delivery of a thrombolytic agent, vasodilator, or other pharmacologic substance directly into the vessel supplying the myocardium, typically during cardiac catheterization for acute coronary syndrome or vasospasm. Because the coronary arteries are small, tortuous, and perfuse tissue with almost no collateral tolerance for ischemia, precise catheter placement and fluoroscopic guidance are essential, and documentation should specify whether the substance reaches a single vessel or multiple coronary branches. Coders must distinguish this from a diagnostic angiogram or from mechanical intervention on the same vessel, since introduction captures only the act of instilling a substance rather than any accompanying dilation or extirpation performed in the same session.
Approach: Open
Open in Administration applies when a substance is introduced directly into a surgically exposed operative site, for instance irrigating an open wound or instilling an antibiotic into an exposed body cavity during surgery. It is distinguished from Percutaneous by the site being fully exposed rather than accessed through a needle puncture.
Substance: Thrombolytic
Thrombolytic covers administration of a substance intended to dissolve an existing blood clot, such as tissue plasminogen activator given in acute ischemic stroke, pulmonary embolism, or myocardial infarction. It is distinguished from Platelet Inhibitor, which prevents new clot formation by blocking platelet aggregation rather than breaking down an established clot, and from Antiarrhythmic, which addresses heart rhythm rather than clot burden.
Qualifier: Recombinant Human-activated Protein C
Refers to administration of drotrecogin alfa, a recombinant form of activated protein C once used to modulate coagulation and inflammation in severe sepsis before being withdrawn from the market. This qualifier is specific to that engineered protein and differs from Other Thrombolytic, which covers clot-dissolving agents rather than this anticoagulant-anti-inflammatory biologic.
Coding & Documentation
Correct code assignment depends on identifying three things from the documentation: the substance given, matched to the correct qualifier value; the specific body region or route receiving it; and the approach used, such as percutaneous injection or an existing catheter. Physician orders and medication administration records are the primary support. The most common errors involve selecting an imprecise substance qualifier, for example coding a general anti-infective when the documentation specifies a particular drug category with its own value, or misidentifying the body region when a substance is delivered systemically versus locally, such as an intra-articular injection versus an intravenous one.
Commonly Confused With
This family is easily confused with Transfusion, but any blood or blood product is excluded here and must be coded under Transfusion instead, regardless of how it is delivered. It is also confused with routine medication administration that some facilities do not code separately when it is considered standard nursing care rather than a notable procedural event; coders should apply their facility's guidelines to determine which introductions rise to the level of a codable procedure.